Keywords COPD NAFLD NASH Pharmacoeconomics QALY budget impact analysis chemotherapy children clinical and economic analysis cost-effectiveness analysis cost-utility analysis drug supply drugs health technology assessment indirect comparison non-alcoholic fatty liver disease pharmacoeconomic analysis pharmacoeconomic studies pharmacoeconomics pharmacoepidemiology rare diseases

Notifications

• View
• Subscribe